NCT00310180 2026-03-18
TAILORx
National Cancer Institute (NCI)
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT02954874 2026-03-17
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT04852887 2026-03-03
DEBRA
NRG Oncology
Phase 3 Recruiting
NCT00066690 2026-02-06
SOFT
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT03488693 2026-01-13
TAILOR RT
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT00805597 2016-08-08
Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes
ChineseAMS
Phase 3 Terminated